Bill > H0209

This bill updates Vermont's law regarding epinephrine administration in schools, making several key changes to improve emergency allergy response. The bill modifies existing regulations to allow schools to maintain a stock supply of epinephrine delivery systems (previously called "auto-injectors") and expands who can administer them in emergency situations. It clarifies definitions, including adding a specific definition for "school nurse" and specifying that epinephrine must be a U.S. Food and Drug Administration-approved single-dose system. The legislation requires schools to develop protocols for recognizing and responding to life-threatening allergic reactions (anaphylaxis), including procedures for preventing allergen exposure, responding to emergencies, and creating individualized allergy management plans. The bill maintains liability protections for school personnel, health care professionals, and the school when administering epinephrine in good faith, and mandates that the State Board, in consultation with the Department of Health, adopt comprehensive policies for managing life-threatening allergies in schools. These policies must include training for school nurses and designated personnel on recognizing and responding to allergic reactions, storing and administering epinephrine, and making emergency protocols publicly available. The bill will take effect on July 1, 2025, giving schools time to implement the new requirements.

Education

https://legislature.vermont.gov/bill/status/2026/H.209